As part of this partnership, Affidea has implemented Skin Analytics’ DERM, an AI medical device software for the automated analysis of skin lesions. The initial implementation of DERM began in Romania ...

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, lipid-lowering drugs, were associated with a 22% lower risk for nonmelanoma skin cancer (NMSC) in patients with atherosclerotic ...

DecisionDx-SCC test predicts local recurrence and metastasis in high-risk cutaneous squamous cell carcinoma, enhancing personalized treatment decisions. The test categorizes patients into three risk ...

"The findings emphasise the need for better, targeted ethnicity data collection strategies to address incidence, outcomes and healthcare equity for not just skin cancer but all health conditions in ...

Between ski days, holiday travel and New Year’s routines, skin cancer prevention often slips off the radar in the Okanagan ...

Older adults face unique risks for skin cancer due to long-term sun exposure and age-related changes. Skin cancer is becoming more common in older adult populations around the world. According to the ...